These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

922 related articles for article (PubMed ID: 23317504)

  • 1. Phospho switch triggers Brd4 chromatin binding and activator recruitment for gene-specific targeting.
    Wu SY; Lee AY; Lai HT; Zhang H; Chiang CM
    Mol Cell; 2013 Mar; 49(5):843-57. PubMed ID: 23317504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation-dependent BRD4 dimerization and implications for therapeutic inhibition of BET family proteins.
    Malvezzi F; Stubbs CJ; Jowitt TA; Dale IL; Guo X; DeGnore JP; Degliesposti G; Skehel JM; Bannister AJ; McAlister MS
    Commun Biol; 2021 Nov; 4(1):1273. PubMed ID: 34754068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNAs interact with BRD4 to promote enhanced chromatin engagement and transcription activation.
    Rahnamoun H; Lee J; Sun Z; Lu H; Ramsey KM; Komives EA; Lauberth SM
    Nat Struct Mol Biol; 2018 Aug; 25(8):687-697. PubMed ID: 30076409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation.
    Wu SY; Chiang CM
    J Biol Chem; 2007 May; 282(18):13141-5. PubMed ID: 17329240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone cross-talk connects protein phosphatase 1α (PP1α) and histone deacetylase (HDAC) pathways to regulate the functional transition of bromodomain-containing 4 (BRD4) for inducible gene expression.
    Hu X; Lu X; Liu R; Ai N; Cao Z; Li Y; Liu J; Yu B; Liu K; Wang H; Zhou C; Wang Y; Han A; Ding F; Chen R
    J Biol Chem; 2014 Aug; 289(33):23154-23167. PubMed ID: 24939842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signal-induced Brd4 release from chromatin is essential for its role transition from chromatin targeting to transcriptional regulation.
    Ai N; Hu X; Ding F; Yu B; Wang H; Lu X; Zhang K; Li Y; Han A; Lin W; Liu R; Chen R
    Nucleic Acids Res; 2011 Dec; 39(22):9592-604. PubMed ID: 21890894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of Brd4 in different steps of the papillomavirus life cycle.
    Iftner T; Haedicke-Jarboui J; Wu SY; Chiang CM
    Virus Res; 2017 Mar; 231():76-82. PubMed ID: 27965149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bromodomain protein Brd4 associated with acetylated chromatin is important for maintenance of higher-order chromatin structure.
    Wang R; Li Q; Helfer CM; Jiao J; You J
    J Biol Chem; 2012 Mar; 287(14):10738-52. PubMed ID: 22334664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brd4 links chromatin targeting to HPV transcriptional silencing.
    Wu SY; Lee AY; Hou SY; Kemper JK; Erdjument-Bromage H; Tempst P; Chiang CM
    Genes Dev; 2006 Sep; 20(17):2383-96. PubMed ID: 16921027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct layers of BRD4-PTEFb reveal bromodomain-independent function in transcriptional regulation.
    Zheng B; Gold S; Iwanaszko M; Howard BC; Wang L; Shilatifard A
    Mol Cell; 2023 Aug; 83(16):2896-2910.e4. PubMed ID: 37442129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NSD3-Short Is an Adaptor Protein that Couples BRD4 to the CHD8 Chromatin Remodeler.
    Shen C; Ipsaro JJ; Shi J; Milazzo JP; Wang E; Roe JS; Suzuki Y; Pappin DJ; Joshua-Tor L; Vakoc CR
    Mol Cell; 2015 Dec; 60(6):847-59. PubMed ID: 26626481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia.
    Zuber J; Shi J; Wang E; Rappaport AR; Herrmann H; Sison EA; Magoon D; Qi J; Blatt K; Wunderlich M; Taylor MJ; Johns C; Chicas A; Mulloy JC; Kogan SC; Brown P; Valent P; Bradner JE; Lowe SW; Vakoc CR
    Nature; 2011 Aug; 478(7370):524-8. PubMed ID: 21814200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic targeting of BET bromodomain and other epigenetic acetylrecognition domain-containing factors.
    Gold S; Shilatifard A
    Curr Opin Genet Dev; 2024 Jun; 86():102181. PubMed ID: 38564841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRD4 is an atypical kinase that phosphorylates serine2 of the RNA polymerase II carboxy-terminal domain.
    Devaiah BN; Lewis BA; Cherman N; Hewitt MC; Albrecht BK; Robey PG; Ozato K; Sims RJ; Singer DS
    Proc Natl Acad Sci U S A; 2012 May; 109(18):6927-32. PubMed ID: 22509028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brd4 marks select genes on mitotic chromatin and directs postmitotic transcription.
    Dey A; Nishiyama A; Karpova T; McNally J; Ozato K
    Mol Biol Cell; 2009 Dec; 20(23):4899-909. PubMed ID: 19812244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRD4 bimodal binding at promoters and drug-induced displacement at Pol II pause sites associates with I-BET sensitivity.
    Khoueiry P; Ward Gahlawat A; Petretich M; Michon AM; Simola D; Lam E; Furlong EE; Benes V; Dawson MA; Prinjha RK; Drewes G; Grandi P
    Epigenetics Chromatin; 2019 Jul; 12(1):39. PubMed ID: 31266503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IDR-targeting compounds suppress HPV genome replication via disruption of phospho-BRD4 association with DNA damage response factors.
    Wu SY; Lai HT; Sanjib Banerjee N; Ma Z; Santana JF; Wei S; Liu X; Zhang M; Zhan J; Chen H; Posner B; Chen Y; Price DH; Chow LT; Zhou J; Chiang CM
    Mol Cell; 2024 Jan; 84(2):202-220.e15. PubMed ID: 38103559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bromodomain-containing protein 4-independent transcriptional activation by autoimmune regulator (AIRE) and NF-κB.
    Huang F; Shao W; Fujinaga K; Peterlin BM
    J Biol Chem; 2018 Apr; 293(14):4993-5004. PubMed ID: 29463681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanistic analysis of the role of bromodomain-containing protein 4 (BRD4) in BRD4-NUT oncoprotein-induced transcriptional activation.
    Wang R; You J
    J Biol Chem; 2015 Jan; 290(5):2744-58. PubMed ID: 25512383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenesis by sequestration of CBP/p300 in transcriptionally inactive hyperacetylated chromatin domains.
    Reynoird N; Schwartz BE; Delvecchio M; Sadoul K; Meyers D; Mukherjee C; Caron C; Kimura H; Rousseaux S; Cole PA; Panne D; French CA; Khochbin S
    EMBO J; 2010 Sep; 29(17):2943-52. PubMed ID: 20676058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.